Buy, hold, sell: NAB, Santos, and Suncorp shares

Let's see what Morgans is saying about these giants.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A number of big names released updates this week and Morgans has been busy running the rule over them.

In response, let's see whether the broker now rates these ASX 200 shares as buys, holds, or sells.

A man looking at his laptop and thinking.

Image source: Getty Images

National Australia Bank Ltd (ASX: NAB)

Morgans was pleased with this big four bank's performance during the first quarter and has upgraded its forecasts to reflect this and its positive outlook.

However, due to its current valuation, the broker has reaffirmed its sell rating with a $37.27 price target. It said:

Like its peers that reported in February, NAB's 1Q26 trading update showed it is benefitting from a supportive interest rate, credit growth, and asset quality environment. We make upgrades to our forecasts to reflect performance and outlook. 12 month target price set at $37.27/sh. With more aggressive assumptions than previously we estimate a higher fundamental value for NAB. However, the share price is still trading far ahead of this revised estimate. SELL retained, with potential TSR of -17% (including 3.6% cash yield).

Santos Ltd (ASX: STO)

Another big name that Morgans has been looking at is energy giant Santos. Morgans thought the company delivered a solid result given the difficult trading conditions.

However, with its shares trading at fair value, the broker has retained its hold rating and $6.80 price target. It explains:

A solid CY25 earnings result from STO under difficult conditions, with lower commodity prices partly offset by solid cost controls and operating performances. Surprisingly large final dividend versus our estimate, with full year dividend payout equivalent to 86% of earnings and funded majority through debt. FCF was back in positive territory at US$208m, with a FCF breakeven of US$58.90/bbl. Strategic review on non-core assets could see some changes to the portfolio (Cooper, WA, Narrabri all being reviewed). We maintain a HOLD rating and A$6.80 target price.

Suncorp Group Ltd (ASX: SUN)

This insurance giant posted a sharp decline in profits during the first half due to unfavourable weather conditions. And while Suncorp also downgraded its guidance for FY 2026 slightly, Morgans remains positive.

It has retained its accumulate rating with a $17.01 price target. It said:

SUN's 1H26 NPAT (A$263m) was well down on the pcp ($1.1bn) due to bad weather, but it was only -2% below consensus ($268m). Overall, we saw this as a reasonable result, albeit similar to key peer IAG, SUN did deliver a mild downgrade to FY26 top-line growth guidance. We make relatively nominal changes to our SUN FY26F/FY27F EPS of -2%/+1% on a review of our earnings assumptions. Our PT is reduced to A$17.01 (previously A$19.28). With >10% upside to our valuation, we maintain our Accumulate rating on SUN.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »